322 related articles for article (PubMed ID: 15289323)
1. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.
Schuierer MM; Bataille F; Hagan S; Kolch W; Bosserhoff AK
Cancer Res; 2004 Aug; 64(15):5186-92. PubMed ID: 15289323
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
3. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma.
Schuierer MM; Bataille F; Weiss TS; Hellerbrand C; Bosserhoff AK
Oncol Rep; 2006 Sep; 16(3):451-6. PubMed ID: 16865242
[TBL] [Abstract][Full Text] [Related]
4. RKIP downregulates B-Raf kinase activity in melanoma cancer cells.
Park S; Yeung ML; Beach S; Shields JM; Yeung KC
Oncogene; 2005 May; 24(21):3535-40. PubMed ID: 15782137
[TBL] [Abstract][Full Text] [Related]
5. Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells.
Ma J; Li F; Liu L; Cui D; Wu X; Jiang X; Jiang H
Liver Int; 2009 Apr; 29(4):567-74. PubMed ID: 19323783
[TBL] [Abstract][Full Text] [Related]
6. Raf kinase inhibitory protein inhibits beta-cell proliferation.
Zhang L; Fu Z; Binkley C; Giordano T; Burant CF; Logsdon CD; Simeone DM
Surgery; 2004 Sep; 136(3):708-15. PubMed ID: 15349122
[TBL] [Abstract][Full Text] [Related]
7. The role of Raf kinase inhibitor protein (RKIP) in health and disease.
Keller ET; Fu Z; Brennan M
Biochem Pharmacol; 2004 Sep; 68(6):1049-53. PubMed ID: 15313400
[TBL] [Abstract][Full Text] [Related]
8. Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma.
Panka DJ; Atkins MB; Mier JW
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2371s-2375s. PubMed ID: 16609061
[TBL] [Abstract][Full Text] [Related]
9. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.
Hagan S; Al-Mulla F; Mallon E; Oien K; Ferrier R; Gusterson B; García JJ; Kolch W
Clin Cancer Res; 2005 Oct; 11(20):7392-7. PubMed ID: 16243812
[TBL] [Abstract][Full Text] [Related]
10. Raf kinase inhibitor protein regulation of raf and MAPK signaling.
Hagan S; Garcia R; Dhillon A; Kolch W
Methods Enzymol; 2006; 407():248-59. PubMed ID: 16757329
[TBL] [Abstract][Full Text] [Related]
11. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
12. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
13. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein.
Keller ET; Fu Z; Brennan M
J Cell Biochem; 2005 Feb; 94(2):273-8. PubMed ID: 15565643
[TBL] [Abstract][Full Text] [Related]
14. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant.
Tsavachidou D; Coleman ML; Athanasiadis G; Li S; Licht JD; Olson MF; Weber BL
Cancer Res; 2004 Aug; 64(16):5556-9. PubMed ID: 15313890
[TBL] [Abstract][Full Text] [Related]
15. Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion.
Mc Henry KT; Montesano R; Zhu S; Beshir AB; Tang HH; Yeung KC; Fenteany G
J Cell Biochem; 2008 Feb; 103(3):972-85. PubMed ID: 17668446
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
[TBL] [Abstract][Full Text] [Related]
17. Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells.
Hellmann J; Rommelspacher H; Mühlbauer E; Wernicke C
Dev Neurosci; 2010 Mar; 32(1):33-46. PubMed ID: 19955695
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
19. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis.
Gao L; Feng Y; Bowers R; Becker-Hapak M; Gardner J; Council L; Linette G; Zhao H; Cornelius LA
Cancer Res; 2006 Aug; 66(16):7880-8. PubMed ID: 16912161
[TBL] [Abstract][Full Text] [Related]
20. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
